Multimodal endovascular reperfusion therapies: Adjunctive antithrombotic agents in acute stroke

Neurology

Volumn 78, Issue 7, 2012, Pages 501-506

  Lazzaro, Marc A ^a   Zaidat, Osama O ^a  

^a FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CILOSTAZOL; CLOPIDOGREL; EPTIFIBATIDE; PRASUGREL; TICLOPIDINE; TIROFIBAN; WARFARIN;

ACUTE DISEASE; ANTICOAGULATION; BRAIN ISCHEMIA; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; HEMOSTASIS; LOADING DRUG DOSE; PRIORITY JOURNAL; REPERFUSION; REVASCULARIZATION; REVIEW; STROKE;

EID: 84858117098     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318246d6a5     Document Type: Review

References (29)

1. Saqqur M, Molina CA, Salam A, et al. Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study. Stroke 2007;38:69-74. (Pubitemid 46035608)
2. Qureshi AI, Siddiqui AM, Kim SH, et al. Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2004;25: 322-328. (Pubitemid 38235318)
3. Alexandrov AV, Grotta JC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 2002;59:862-867.
4. Alexandrov AV, Molina CA, Grotta JC, et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004;351:2170-2178. (Pubitemid 39507629)
5. The Interventional Management of Stroke (IMS) II Study. Stroke 2007;38:2127-2135.
6. Eckert B, Kucinski T, Neumaier-Probst E, Fiehler J, Rother J, Zeumer H. Local intra-arterial fibrinolysis in acute hemispheric stroke: effect of occlusion type and fibrinolytic agent on recanalization success and neurological outcome. Cerebrovasc Dis 2003;15:258-263. (Pubitemid 36438729)
7. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke: PROACT Investigators: Prolyse in Acute Cerebral Thromboembolism. Stroke 1998;29:4-11. (Pubitemid 28046933)
8. Janjua N, Alkawi A, Suri MF, Qureshi AI. Impact of arterial reocclusion and distal fragmentation during thrombolysis among patients with acute ischemic stroke. AJNR Am J Neuroradiol 2008;29:253-258. (Pubitemid 351287876)
9. Schumacher HC, Meyers PM, Higashida RT, et al. Reporting standards for angioplasty and stent-assisted angioplasty for intracranial atherosclerosis. Stroke 2009;40: e348-e365.
10. Nahab F, Walker GA, Dion JE, Smith WS. Safety of Periprocedural Heparin in Acute Ischemic Stroke Endovascular Therapy: The Multi MERCI Trial. J Stroke Cerebrovasc Dis Epub 2011 Jun 1.
11. Abciximab in acute ischemic stroke: a randomized, double-blind, placebo-controlled, dose-escalation study: The Abciximab in Ischemic Stroke Investigators. Stroke 2000;31:601-609.
12. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial. Stroke 2005;36:880-890.
13. Adams HP Jr, Effron MB, Torner J, et al. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke 2008;39:87-99.
14. Lee DH, Jo KD, Kim HG, et al. Local intraarterial urokinase thrombolysis of acute ischemic stroke with or without intravenous abciximab: a pilot study. J Vasc Interv Radiol 2002;13:769-774.
15. Qureshi AI, Harris-Lane P, Kirmani JF, et al. Intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke: an open-label, dose-ranging, phase I study. Neurosurgery 2006;59:789-796; discussion 796-787.
16. Deshmukh VR, Fiorella DJ, Albuquerque FC, et al. Intraarterial thrombolysis for acute ischemic stroke: preliminary experience with platelet glycoprotein IIb/IIIa inhibitors as adjunctive therapy. Neurosurgery 2005;56:46-54. (Pubitemid 40053975)
17. Mangiafico S, Cellerini M, Nencini P, et al. Intravenous glycoprotein IIb/III inhibitor (tirofiban) followed by intraarterial urokinase and mechanical thrombolysis in stroke. AJNJR Am J Neuroradiol 2005;26:2595-2601.
18. Lee KY, Heo JH, Lee SI, Yoon PH. Rescue treatment with abciximab in acute ischemic stroke. Neurology 2001;56: 1585-1587. (Pubitemid 32536818)
19. Stroke Trials Registry. Available at: http://www.stroke center.org/trials/trialDetail.aspx?tid=462. Accessed August 7, 2011.
20. Seitz RJ, Hamzavi M, Junghans U, Ringleb PA, Schranz C, Siebler M. Thrombolysis with recombinant tissue plasminogen activator and tirofiban in stroke: preliminary observations. Stroke 2003;34:1932-1935. (Pubitemid 36944783)
21. Seitz RJ, Meisel S, Moll M, Wittsack HJ, Junghans U, Siebler M. The effect of combined thrombolysis with rtPA and tirofiban on ischemic brain lesions. Neurology 2004; 62:2110-2112. (Pubitemid 38738234)
22. Stroke Trials Registry. Available at: http://www.stroke center.org/trials/TrialDetail.aspx?tid=593. Accessed August 7, 2011.
23. Pancioli AM, Broderick J, Brott T, et al. The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial. Stroke 2008;39: 3268-3276.
24. CLEAR-ER Clinical Trial: http://clinicaltrials.gov/ct2/ show/NCT00894803. Accessed 2011.
25. Gupta R, Vora NA, Horowitz MB, et al. Multimodal reperfusion therapy for acute ischemic stroke: factors predicting vessel recanalization. Stroke 2006;37:986-990.
26. Steg PG, Dorman SH, Amarenco P. Atherothrombosis: the role of antiplatelet therapy. J Thromb Haemost 2011; 9(suppl 1):325-332.
27. Coull BM, Williams LS, Goldstein LB, et al. Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). Stroke 2002;33:1934-1942. (Pubitemid 34761088)
28. Levy EI, Siddiqui AH, Crumlish A, et al. First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke). Stroke 2009;40:3552-3556.
29. Meyers PM, Schumacher HC, Higashida RT, et al. Indications for the performance of intracranial endovascular neurointerventional procedures: a scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation 2009;119:2235-2249.